glp 1 news GLP-1 Prescriptions Quadruple Since 2021 Alongside Decline In Obesity Glp-1 news. This is truly

Notably, GLP-1RAs slow the transit time of the gastrointestinal (GI) tract and suppress appetite, which could displace nutrient intake and result in mineral and vitamin deficiencies

Clinical trials consistently show that people lose 12 to 18 percent of their body weight when taking these medications along with lifestyle changes

They should set realistic expectations, monitor key metabolic markers, and reinforce lifestyle measures through multidisciplinary support

NPs play a key role in addressing these barriers, advocating for patients, and promoting informed, stigma-free discussions that support safe and equitable use

Until a couple months ago, these medications were only available as injectables, which discouraged some patients